-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/FactorsToConsiderInManagingChronicPain_Change_Log.txt
January 01, 2024 - and add non-Opioid pain
medications instead
- Add note (in comments) about excluding patients with sickle … cell disease
- Add opioid tapering to risk factors for opioid-related harms
- Add adjuvant pain medications … and add non-Opioid pain
medications instead
- Add note (in comments) about excluding patients with sickle … cell disease
- Add opioid tapering to risk factors for opioid-related harms
- Add adjuvant pain medications
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Included language about sickle cell disease to
reflect changes in the CDC guidelines. … cell disease, in active cancer treatment, palliative care, or
end-of-life care). … • The CDC exclusion criteria (sickle cell disease, active cancer treatment, palliative care,
and … cell disease
The CDC guidelines do not apply to individuals who have sickle cell disease or are undergoing … cell disease or are
receiving end-of-life care or cancer treatment.”